Frederick G. Vogt, Interim CEO & General Counsel at IOVANCE BIOTHERAPEUTICS, INC. (IOVA), bought 1,000 shares at $5.98 ($6K) on 2022-11-28, disclosed to the SEC on 2022-11-28.
Open-market purchase of $6k IOVA by Interim CEO & General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |